Dmitry Kaminskiy on the Longevity Industry in the UK
“The one billion retired people globally are a multi-trillion dollar opportunity for business,” said Dmitry Kaminskiy, co-author of the UK Longevity Industry Report and managing partner of Deep Knowledge Ventures, who was a panellist at last week’s event.
Would you want to live to 180? The technology to do so may soon exist
As for the goal of living beyond 180, Kaminskiy thinks that in five years "we will be able to provide more tangible forecasting. There's not enough data yet." But he says with the information we have now, living to 123 "is absolutely realistic."
The Future of Longevity
Dmitry Kaminskiy was recently interviewed by futurist Trond Arne Undheim on the podcast 𝐅𝐮𝐭𝐮𝐫𝐢𝐳𝐞𝐝: 𝐓𝐡𝐨𝐮𝐠𝐡𝐭 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐨𝐧 𝐎𝐮𝐫 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐅𝐮𝐭𝐮𝐫𝐞
South Korea and China earn high marks in pandemic safety ranking
"The countries that will be able to provide long-lasting protection for their citizens, and stay stable, they will to some extent automatically attract financial activity," Dmitry Kaminsky, DKV's founder and managing partner, told the Nikkei Asian Review.
An Interview to Nikkei Asian Review on the topic of DKG's COVID-19 Rankings.
But last week, when a Hong Kong venture fund ranked the safest places to be during the pandemic, Israel came out on top. Deep Knowledge Ventures, which made headlines in 2014 for appointing AI to its board, assessed countries based on 76 parameters.
How longevity will boost the silver economy
There is no need to say that keeping in good health and living independently and with a good quality of life is every ageing person’s goal. Entrepreneur and longevity investor Dmitry Kaminskiy believes that “technology in general, and DeepTech (...) will be the main driver of improved quality of life, social activity, performance and independence, and the extension of the healthy period of life” among older persons. Co-founder and managing partner at Deep Knowledge Ventures, Kaminskiy is co-director of the secretariat of the All-Party Parliamentary Group for Longevity in the UK Parliament.
People Are Living Longer, But Not Better—A New Social Contract Is Needed
Dmitry Kaminskiy summarized the core message of the Summit, “Britain’s national assets could be deployed to tackle the challenges and develop the opportunities of a longer, healthier life - to create a longevity dividend that can be shared fairly to all in society - and become the world's leader in healthy longevity.”
Venture Capitalist Promises $1M To First Person To Reach 123rd Birthday
Venture capitalist Dmitry Kaminskiy thinks he has what it takes to lengthen people's life spans: a million-dollar prize, which he will award to the first person to beat the current longevity record and reach his or her 123rd birthday.
World’s most innovative country clocks Agetech
Dmitry Kaminskiy, co-founder of the Longevity Swiss Foundation and general partner at Deep Knowledge Ventures, said: “Switzerland has a long-standing reputation as a hub for both international policy and the financial industry.
Artificial intelligence: The rise of the responsible robots
Yuval Noah Harari, the best-selling author of Sapiens and Homo Deus, wrote in the latter book about the case of an algorithm that was appointed to the boardroom of a venture capital firm.
该相信人工智能还是人类的直觉?
位于香港的投资公司Deep Knowledge Ventures在2014年因为在董事会引入计算机算法而声名大振。该公司旗下管理的资产约为1亿欧元，希望找到一种方法来实施数据驱动型的投资策略，而不是依靠人类的直觉以及与创始人之间的关系。执行合伙人德米特里·卡明斯基（Dmitry Kaminskiy）
Managers Need to Understand A.I. Logic Before Using It as a Business Tool
Deep Knowledge Ventures, which has about 100 million euros under management, wanted a way to enforce a data-driven approach to investing, rather than relying on human intuition and personal interactions with founders.
Two Longevity Experts Bet $1 Million Over Who Dies First
Longevity bet was between Dmitry Kaminskiy, who works at the firm Deep Knowledge Ventures, and Dr. Alex Zhavoronkov, who runs Insilico Medicine Inc.
.png)
Venture Capital Firm Hires Artificial Intelligence To Its Board Of Directors
Deep Knowledge Ventures said that the AI would help make financial and business decisions, help lead its research into biotechnology and regenerative medicine, and would act as an "equal member of the board".
